D. E. Shaw & Co., Inc. Novo Cure LTD Call Options Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $251,562 - $331,409	3,700 New	3,700 $281,000
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $1.35 Million - $2.07 Million	-10,900 Reduced 52.15%	10,000 $1.32 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $1.22 Million - $1.9 Million	10,900 Added 109.0%	20,900 $3.62 Million
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $683,000 - $938,000	10,000 New	10,000 $843,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.25B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.